Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer

Shivaani Kummar, James L. Wade, Amit M. Oza, Daniel Sullivan, Alice P. Chen, David R. Gandara, Jiuping Ji, Robert J. Kinders, Lihua Wang, Deborah Allen, Geraldine O’Sullivan Coyne, Seth M. Steinberg, James H. Doroshow

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences